ADAR1 Capital Management »

Newamsterdam Pharma Co Nv shares owned by ADAR1 Capital Management

Quarter-by-quarter ownership of Newamsterdam Pharma Co Nv (NAMSW) shares owned by ADAR1 Capital Management from 13F filings

Historical chart of ADAR1 Capital Management investment in Newamsterdam Pharma Co Nv

Tip: Access up to 7 years of quarterly data

All positions including Newamsterdam Pharma Co Nv held by ADAR1 Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Newamsterdam Pharma Co Nv by ADAR1 Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $259k 83k 3.13

More positions owned by ADAR1 Capital Management

Alnylam Pharmaceuticals (ALNY)
Royalty Pharma Shs Class A (RPRX)
Keros Therapeutics (KROS)
Roivant Sciences SHS (ROIV)
Cytokinetics Com New (CYTK)
Arbutus Biopharma (ABUS)
Bridgebio Pharma (BBIO)
Merrimack Pharmaceuticals In Com New (MACK)
Cerevel Therapeutics Hldng I (CERE)
Mirati Therapeutics
Merck & Co (MRK)
Ascendis Pharma A/s Sponsored Adr (ASND)
Immunovant (IMVT)
Viking Therapeutics (VKTX)
Protagonist Therapeutics (PTGX)

View all positions for ADAR1 Capital Management

Top funds holding Newamsterdam Pharma Co Nv

Frazier Life Sciences Management
RA Capital Management
Deerfield Management Company
ADAR1 Capital Management
Millennium Management
EcoR1 Capital
Westchester Capital Management
Hrt Financial
Walleye Trading Advisors
Laurion Capital Management
Walleye Trading

View all funds holding Newamsterdam Pharma Co Nv